142 related articles for article (PubMed ID: 18217142)
1. Magnitude and time course of platelet inhibition with extended release dipyridamole with or without aspirin in healthy Japanese volunteers. The AGgrenox versus Aspirin Therapy Evaluation (AGATE-Japan).
Serebruany VL; Malinin AI; Hanley DF
Thromb Haemost; 2008 Jan; 99(1):116-20. PubMed ID: 18217142
[TBL] [Abstract][Full Text] [Related]
2. Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial.
Serebruany VL; Malinin AI; Sane DC; Jilma B; Takserman A; Atar D; Hennekens CH
Eur J Pharmacol; 2004 Sep; 499(3):315-24. PubMed ID: 15381054
[TBL] [Abstract][Full Text] [Related]
3. Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?
Serebruany VL; Malinin AI; Sane DC
Am J Hematol; 2003 Apr; 72(4):280-1. PubMed ID: 12666142
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
5. Dipyridamole decreases protease-activated receptor and annexin-v binding on platelets of post stroke patients with aspirin nonresponsiveness.
Serebruany V; Malinin A; Ziai W; Atar D; Pokov A; Jilma B; Hanley D
Cerebrovasc Dis; 2006; 21(1-2):98-105. PubMed ID: 16340184
[TBL] [Abstract][Full Text] [Related]
6. The Japanese aggrenox (extended-release dipyridamole plus aspirin) stroke prevention versus aspirin programme (JASAP) study: a randomized, double-blind, controlled trial.
Uchiyama S; Ikeda Y; Urano Y; Horie Y; Yamaguchi T
Cerebrovasc Dis; 2011; 31(6):601-13. PubMed ID: 21502757
[TBL] [Abstract][Full Text] [Related]
7. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in patients after recent ischemic stroke: for the Plavix Use for Treatment of Stroke (PLUTO-Stroke) trial.
Serebruany VL; Malinin AI; Ziai W; Pokov AN; Bhatt DL; Alberts MJ; Hanley DF
Stroke; 2005 Oct; 36(10):2289-92. PubMed ID: 16151033
[TBL] [Abstract][Full Text] [Related]
8. Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin.
Guthikonda S; Lev EI; Patel R; DeLao T; Bergeron AL; Dong JF; Kleiman NS
J Thromb Haemost; 2007 Mar; 5(3):490-6. PubMed ID: 17319904
[TBL] [Abstract][Full Text] [Related]
9. Effects of Aggrenox and aspirin on plasma endothelial nitric oxide synthase and oxidised low-density lipoproteins in patients after ischaemic stroke. The AGgrenox versus aspirin therapy evaluation (AGATE) biomarker substudy.
Serebruany V; Sani Y; Eisert C; Schevchuck A; Fong A; Hanley D
Thromb Haemost; 2011 Jan; 105(1):81-7. PubMed ID: 20978715
[TBL] [Abstract][Full Text] [Related]
10. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
[TBL] [Abstract][Full Text] [Related]
11. Aggrenox: an aspirin and extended-release dipyridamole combination.
Wong NN
Heart Dis; 2001; 3(5):340-6. PubMed ID: 11975816
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antiplatelet effects of clopidogrel plus acetylsalicylic acid compared with acetylsalicylic acid alone or combined with extended-release dipyridamole in healthy volunteers.
Caplain H
Cerebrovasc Dis; 2005; 19(4):214-9. PubMed ID: 15703464
[TBL] [Abstract][Full Text] [Related]
13. The in vitro effects of niacin on platelet biomarkers in human volunteers.
Serebruany V; Malinin A; Aradi D; Kuliczkowski W; Norgard NB; Boden WE
Thromb Haemost; 2010 Aug; 104(2):311-7. PubMed ID: 20539903
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of the antiplatelet combination aspirin (acetylsalicylic acid) plus extended-release dipyridamole are not altered by coadministration with the potent CYP2C19 inhibitor omeprazole.
Offman E; Schobelock MJ; Brickl R; VanderMaelen CP; Ehrlich J; Eisert W
Am J Cardiovasc Drugs; 2013 Apr; 13(2):113-20. PubMed ID: 23532686
[TBL] [Abstract][Full Text] [Related]
15. Extended-release dipyridamole/aspirin.
Hervey PS; Goa KL
Drugs; 1999 Sep; 58(3):469-75; discussion 476-7. PubMed ID: 10493274
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
[TBL] [Abstract][Full Text] [Related]
17. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
[TBL] [Abstract][Full Text] [Related]
18. Effect of a single dose aspirin on platelets in humans with multiple risk factors for coronary artery disease.
Malinin AI; Atar D; Callahan KP; McKenzie ME; Serebruany VL
Eur J Pharmacol; 2003 Feb; 462(1-3):139-43. PubMed ID: 12591106
[TBL] [Abstract][Full Text] [Related]
19. Aggrenox: a fixed-dose combination of aspirin and dipyridamole.
Lenz TL; Hilleman DE
Ann Pharmacother; 2000 Nov; 34(11):1283-90. PubMed ID: 11098344
[TBL] [Abstract][Full Text] [Related]
20. Effects of two preparations of 75-mg extended-release aspirin on platelet aggregation, prostanoids and nitric oxide production in humans.
de la Cruz JP; Guerrero A; González-Correa JA; Márquez E; Nacle I; Sánchez de la Cuesta F
Eur J Clin Pharmacol; 2002 Jan; 57(11):775-80. PubMed ID: 11871383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
